Pfizer begins early stage trial for oral COVID-19 drug

Mar 24, 2021

New York [US], March 24 : Pfizer has said that it has begun early-stage clinical trials of an investigational, oral antiviral drug for Covid-19.

Pfizer says its COVID-19 oral antiviral candidate reduces risk of hospitalisation by 89pc

Nov 05, 2021

New York [US], November 5 : American pharmaceutical company Pfizer announced on Friday that its investigational COVID-19 oral antiviral candidate, Paxlovid, showed an 89...

Hospitalized patients with advanced COVID-19 who received remdesivir recovered faster than those who received placebo: NIAID

Apr 30, 2020

Washington D.C. [US], April 30 : A preliminary data analysis from NIH clinical trial shows that hospitalized patients with "advanced COVID-19 and lung involvement...

SEC to take decision on antiviral Covid pill today

Dec 27, 2021

New Delhi [India], December 27 : After reviewing all applications and data on antiviral pills, the Subject expert committee (SEC) a body under India's...

Remdesivir included in 'investigational therapy' for restricted emergency use on COVID-19 patients: Health Ministry

Jun 14, 2020

New Delhi [India], June 14 : Union Health Ministry on Sunday said that drug Remdesivir has been included as an "investigational therapy" only for...

CSIR gets nod for Phase III trial of antiviral drug Umifenovir

Jun 19, 2020

New Delhi [India], June 19 : CSIR constituent lab CSIR-Central Drug Research Institute (CDRI) Lucknow has received permission for carrying out Phase III trial...